Jazz Pharmaceuticals (NASDAQ:JAZZ) Rating Reiterated by Truist Financial
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report)‘s stock had its “buy” rating reissued by Truist Financial in a research report issued on Wednesday, Benzinga reports. They currently have a $200.00 price target on the specialty pharmaceutical company’s stock. Truist Financial’s target price points to a potential upside of 61.16% from the company’s current price. JAZZ […]
More Stories
Truvestments Capital LLC Buys New Position in BellRing Brands, Inc. (NYSE:BRBR)
Truvestments Capital LLC acquired a new position in BellRing Brands, Inc. (NYSE:BRBR – Free Report) during the 3rd quarter, HoldingsChannel.com...
Inter Parfums, Inc. (NASDAQ:IPAR) COO Pelayo Frederic Garcia Sells 4,000 Shares
Inter Parfums, Inc. (NASDAQ:IPAR – Get Free Report) COO Pelayo Frederic Garcia sold 4,000 shares of the stock in a...
Truvestments Capital LLC Invests $39,000 in Main Street Capital Co. (NYSE:MAIN)
Truvestments Capital LLC purchased a new position in shares of Main Street Capital Co. (NYSE:MAIN – Free Report) in the...
Truvestments Capital LLC Purchases Shares of 392 Target Co. (NYSE:TGT)
Truvestments Capital LLC purchased a new stake in Target Co. (NYSE:TGT – Free Report) during the 3rd quarter, according to...
Truvestments Capital LLC Takes Position in Fidelity Low Volatility Factor ETF (NYSEARCA:FDLO)
Truvestments Capital LLC purchased a new stake in shares of Fidelity Low Volatility Factor ETF (NYSEARCA:FDLO – Free Report) in...
Brown Brothers Harriman & Co. Has $247,000 Holdings in GSK plc (NYSE:GSK)
Brown Brothers Harriman & Co. lowered its stake in shares of GSK plc (NYSE:GSK – Free Report) by 18.3% during...